Invitation: On May 10-11,"​ε☆ 2024, Haibu Pharmaceutical≈∞©π invites you to gather in Beijin♠×∞g for the CPI 2024 China P≤₩harmaceutical Industry Ex →po.

Beijing Haibu Pharmaceutical Technol→±↕ogy Co., Ltd. (referred ∑★to as "Haibu Pharmaceuti€ε₽cal") was established in 2005 and™≠ is a high-tech enterprise with "che₩≠mical drug research and develδ♦γopment" as its core capability. It ha✘♠γs a research and devγγ•elopment center in Beijβ ♦ing, a pilot verification ce>'≤γnter for raw materials and forγ≈Ωmulations, and a GMP industrial€✘§ production base, mainly engaged ÷₩☆&in CRO services for raw m‍™↔♣aterials and formulatσ'Ω₽ions, MAH joint lice±↕≠nsing, related applications for raw mat §±erials, and commercial supply of phar ₽φmaceutical intermedi♣​σates.It has rich experience in th$λ₩e research and produc€λ↕tion transfer, registration applica<‍ βtion, etc., of vario÷"us dosage forms such as chemical σΩλ☆raw materials, oral soli<÷ds, liquid preparations, sterile inje>£→©ctions, and external p'☆ε☆reparations. The R&D pr©λ¶§oducts cover multiple therapeuti≠γc areas including anti-tumor, anti-£∑γ×depression, anti-epilepsy, anti-anxietyσ×$, cardiovascular and cereb♣↓↔↔rovascular diseases, d®§∞igestive system, respirat≈"δ&ory system, etc.

Haibu Pharmaceutical hα♥®as been awarded the ♦>title of "Top 20 Chinese P✘←©harmaceutical R&D Comp<☆§anies" for many consec÷÷βutive years and has been re ≠←cognized as a "Specia↕♦γβlized and Innovative" enterprise in Be£β☆ijing, a "National High-tec→π♠ h Enterprise", a "Beijing Scien♠§÷ce and Technology Rese✔ ↑arch Development Ins←≤ππtitution", and a "Beijing Y↔♥✘✔izhuang Enterprise Innovati&↔ on Center", among othersφφ↔ε.